Phibro Animal Health reported $3.11M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Ani Pharmaceuticals ANIP:US $ 6.61M 2.17M
Aurora Cannabis Inc ACB:CN 25.8M 9.89M
Bristol Myers Squibb BMY:US $ 326M 3M
Eli Lilly And LLY:US $ 84.9M 3.5M
Endo International Ordinary Shares ENDP:US $ 135.07M 8.53M
Henry Schein HSIC:US $ 7M 1.19M
Idexx Laboratories IDXX:US $ 7M 0.48M
JAZZ PHA JAZZ:US $ 70.88M 17.81M
Knight Therapeutics Inc GUD:CN C$ 1.11M 220K
Lannett LCI:US $ 14.52M 0.09M
Merk MRK:US $ 243M 34M
Nektar Therapeutics NKTR:US $ 7.53M 0.6M
Pacira Pharmaceuticals PCRX:US $ 10.25M 0.18M
Patterson Companies PDCO:US $ 4.88M 0.64M
Phibro Animal Health PAHC:US $ 3.11M 0.01M
Prestige Brands PBH:US $ 15.97M 0.95M
Supernus Pharmaceuticals SUPN:US $ 1.16M 3.95M
Teva Pharmaceutical Industries TEVA:US $ 238M 58M
Zoetis ZTS:US $ 53M 1M